Technology Insight: Innovative options for end-stage renal disease - From kidney refurbishment to artificial kidney

Nature Clinical Practice Nephrology

Volumn 3, Issue 10, 2007, Pages 564-572

  Braam, Branko ^a,b   Verhaar, Marianne C ^c   Blankestijn, Peter ^d   Boer, Walther H ^d   Joles, Jaap A ^d  

^a Department of Medicine

^b UNIVERSITY OF ALBERTA   (Canada)

^c Department of Vascular Medicine ^*

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Renal replacement therapy; Stem cells; Therapeutic cloning; Tissue engineering; Transplantation

Indexed keywords

BETA GALACTOSIDASE; ENALAPRIL; ERYTHROPOIETIN;

ARTIFICIAL KIDNEY; BRAIN; C57BL 6 MOUSE; CELL NUCLEUS TRANSPLANTATION; EMBRYONIC STEM CELL; HEART; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY; KIDNEY FAILURE; LUNG; MONKEY; MOUSE STRAIN; NONHUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SODIUM RESTRICTION; SPONTANEOUSLY HYPERTENSIVE RAT; SWINE; TISSUE ENGINEERING; ULTRAFILTRATION;

ANIMALS; EMBRYONIC STEM CELLS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; KIDNEY, ARTIFICIAL; RENAL DIALYSIS; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS;

EID: 34748879388     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0600     Document Type: Review

References (60)

1. Vanholder R et al. (2005) The European artificial organ scene: present status. Artif Organs 29: 498-506
2. Humes HD et al. (2006) The future of hemodialysis membranes. Kidney Int 69: 1115-1119
3. Kooistra MP (2003) Frequent prolonged home haemodialysis: three old concepts, one modern solution. Nephrol Dial Transplant 18: 16-19
4. Eknoyan G et al. (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019
5. Penne EL et al. (2005) Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study. Semin Dial 18: 47-51
6. Ward RA (2005) Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application? J Am Soc Nephrol 16: 2421-2430
7. Leonard EF et al. (2004) Dialysis without membranes: how and why? Blood Purif 22: 92-100
8. Humes HD et al. (1999) Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 55: 2502-2514
9. Diaz-Buxo JA (2005) Access and continuous flow peritoneal dialysis. Perit Dial Int 25 (suppl 3): S102-S104
10. Hoff CM and Shockley TR (2002) Peritoneal dialysis in the 21st century: the potential of gene therapy. J Am Soc Nephrol 13 (suppl 1): S117-S124
11. Kozlowski T et al. (1998) Depletion of anti-Gal(alpha)1-3Gal antibody in baboons by specific alpha-Gal immunoaffinity columns. Xenotransplantation 5: 122-131
12. McKenzie IF et al. (1999) Definition and characterization of chicken Gal alpha(1,3)Gal antibodies. Transplantation 67: 864-870
13. Zhong R et al. (2003) Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation 75: 10-19
14. Lai L et al. (2002) Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295: 1089-1092
15. Yamada K et al. (2005) Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11: 32-34
16. Soin B et al. (2001) Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 60: 1592-1597
17. Butler D (1998) Last chance to stop and think on risks of xenotransplants. Nature 391: 320-324
18. Paradis K et al. (1999) Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 285: 1236-1241
19. Wilson CA et al. (2000) Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol 74: 49-56
20. Nissenson AR et al. (2005) The human nephron filter: toward a continuously functioning, implantable artificial nephron system. Blood Purif 23: 269-274
21. Drexler KE (2003) If atomic precision is unfeasible, so is life. Nature 422: 257
22. Shin M et al. (2004) Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed Microdevices 6: 269-278
23. Brodie JC and Humes HD (2005) Stem cell approaches for the treatment of renal failure. Pharmacol Rev 57: 299-313
24. Atala A and Koh CJ (2004) Tissue engineering applications of therapeutic cloning. Annu Rev Biomed Eng 6: 27-40
25. Laflamme MA and Murry CE (2005) Regenerating the heart. Nat Biotechnol 23: 845-856
26. Steer DL and Nigam SK (2004) Developmental approaches to kidney tissue engineering. Am J Physiol Renal Physiol 286: F1-F7
27. Woolf AS et al. (1990) Creation of a functioning chimeric mammalian kidney. Kidney Int 38: 991-997
28. Rogers SA et al. (1998) Transplantation of developing metanephroi into adult rats. Kidney Int 54: 27-37
29. Dekel B et al. (2002) Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development. J Am Soc Nephrol 13: 977-990
30. Schmidt-Ott KM et al. (2005) Novel regulators of kidney development from the tips of the ureteric bud. J Am Soc Nephrol 16: 1993-2002
31. Rookmaaker MB et al. (2002) Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy. Blood 99: 1095
32. Cornacchia F et al. (2001) Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest 108: 1649-1656
33. Imasawa T et al. (2001) The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 12: 1401-1409
34. Kale S et al. (2003) Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112: 42-49
35. Gupta S et al. (2002) A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 62: 1285-1290
36. Feng Z et al. (2005) Glomerular aging in females is a multi-stage reversible process mediated by phenotypic changes in progenitors. Am J Pathol 167: 355-363
37. Oliver JA et al. (2004) The renal papilla is a niche for adult kidney stem cells. J Clin Invest 114: 795-804
38. Maeshima A et al. (2006) Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol 17: 188-198
39. Lange C et al. (2005) Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68: 1613-1617
40. Little MH (2006) Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 17: 2390-2401
41. Choi JH et al. (2004) Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24: 1246-1252
42. Lin F et al. (2005) Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115: 1756-1764
43. Duffield JS et al. (2005) Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115: 1743-1755
44. Thomson JA et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147
45. Lanza RP et al. (2002) Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol 20: 689-696
46. Koh CJ and Atala A (2004) Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol 15: 1113-1125
47. Okie S (2005) Stem-cell research - signposts and roadblocks. N Engl J Med 353: 1-5
48. Chung Y et al. (2006) Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439: 216-219
49. Solter D (2000) Mammalian cloning: advances and limitations. Nat Rev Genet 1: 199-207
50. Hochedlinger K and Jaenisch R (2003) Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med 349: 275-286
51. Tamashiro KL et al. (2002) Cloned mice have an obese phenotype not transmitted to their offspring. Nat Med 8: 262-267
52. Gluckman PD and Hanson MA (2004) Living with the past: evolution, development, and patterns of disease. Science 305: 1733-1736
53. Henderson LW (2000) Future developments in the treatment of end-stage renal disease: a North American perspective. Am J Kidney Dis 35 (suppl S): S106-S116
54. Bateson P et al. (2004) Developmental plasticity and human health. Nature 430: 419-421
55. Barker DJ (2004) The developmental origins of well-being. Philos Trans R Soc Lond B Biol Sci 359: 1359-1366
56. Racasan S et al. (2005) Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon. Am J Physiol Renal Physiol 288: F626-F636
57. Racasan S et al. (2004) Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension 44: 83-88
58. Lundie MJ et al. (1997) Long-term inhibition of the renin-angiotensin system in genetic hypertension: analysis of the impact on blood pressure and cardiovascular structural changes. J Hypertens 15: 339-348
59. Smallegange C et al. (2004) Persistent lowering of pressure by transplanting kidneys from adult spontaneously hypertensive rats treated with brief antihypertensive therapy. Hypertension 44: 89-94
60. Julius S et al. (2006) Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354: 1685-1697